Shanghai Shenqi Pharmaceutical Investment Management Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Shenqi Pharmaceutical Investment Management has a total shareholder equity of CN¥2.4B and total debt of CN¥231.6M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are CN¥3.2B and CN¥788.6M respectively. Shanghai Shenqi Pharmaceutical Investment Management's EBIT is CN¥105.5M making its interest coverage ratio 41.2. It has cash and short-term investments of CN¥874.1M.
Key information
9.6%
Debt to equity ratio
CN¥231.57m
Debt
| Interest coverage ratio | 41.2x |
| Cash | CN¥874.14m |
| Equity | CN¥2.42b |
| Total liabilities | CN¥788.60m |
| Total assets | CN¥3.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600613's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥600.1M).
Long Term Liabilities: 600613's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥188.5M).
Debt to Equity History and Analysis
Debt Level: 600613 has more cash than its total debt.
Reducing Debt: 600613's debt to equity ratio has increased from 6.4% to 9.6% over the past 5 years.
Debt Coverage: 600613's debt is well covered by operating cash flow (99.8%).
Interest Coverage: 600613's interest payments on its debt are well covered by EBIT (41.2x coverage).